Daniquidone
Term · Oncology and biomedicine · MLC-T-ONC-012911
A water-insoluble heterocyclic amide with potential antineoplastic activity. Daniquidone inhibits topoisomerases I and II, thereby inhibiting DNA replication and repair, and RNA and protein synthesis. The acetylated form of daniquidone is highly toxic and is capable of inducing unscheduled DNA synthesis; rapid acetylators are more likely to experience toxicity with this agent.
| Identifier | MLC-T-ONC-012911 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | batracylin |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-012911",
"term": "Daniquidone",
"field": "Oncology and biomedicine",
"definition": "A water-insoluble heterocyclic amide with potential antineoplastic activity. Daniquidone inhibits topoisomerases I and II, thereby inhibiting DNA replication and repair, and RNA and protein synthesis. The acetylated form of daniquidone is highly toxic and is capable of inducing unscheduled DNA synthesis; rapid acetylators are more likely to experience toxicity with this agent.",
"synonyms": [
"batracylin"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/daniquidone/"
}
Record 5,677 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.